glp-1 receptor agonists are contraindicated in for the Reduction of Atherosclerotic Cardiovascular Risk Patients With Type 2 Diabetes Current Insights, Advantages and Challenges
Description
mg = milligrams
Eur J Health Econ
By addressing these critical issues, this review aims to provide insights into optimizing post-transplant care and improving outcomes of patient and liver allograft survival
Gastrointestinal side effects, frequently observed across this drug class, pose additional challenges for adherence, particularly in populations with high vulnerability to treatment dropout
Although, at first glance, it is easy to overestimate the findings and assume they apply to everyone, this studys participants were a very specific group: older adults with type 2 diabetes
